Is High-Yield Pfizer Stock Still a Buy After Scrapping Its Weight-Loss Pill?The Motley Fool • 04/15/25
Pfizer Halts Development of Obesity Drug After Patient Sustains 'Liver Injury'Investopedia • 04/14/25
Pfizer is halting development of its experimental weight-loss pill, as the booming obesity drug market remains out of reach for the drug giantWSJ • 04/14/25
As the market dips, I'm eyeing dividend plays like KO and PM – what stocks are on your buy list right now?24/7 Wall Street • 04/13/25
6 Stocks With Clear Price Dislocations That I Purchased During Wall Street's Historic VolatilityThe Motley Fool • 04/11/25
Trump Wants RFK Jr. To 'Go Wild' On Health Care. What This Means For Biotech Stocks.Investors Business Daily • 04/10/25
Pfizer Invites Shareholders to Attend Virtual 2025 Annual Meeting of Shareholders on April 24Business Wire • 04/10/25
Autos, pharma, luxury and more: The global sectors soaring after Trump's tariffs walkbackCNBC • 04/10/25
Trump's Tariffs Circle Pharma Industry: Who It Affects And How It May Play OutSeeking Alpha • 04/09/25